Karuna Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.50 M
as on 04-12-2024
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 04-12-2024
- Revenue -5.91%
(FY 2022)
- Profit -38.70%
(FY 2022)
- Ebitda 62.77%
(FY 2022)
- Net Worth 11.16%
(FY 2022)
- Total Assets 10.89%
(FY 2022)
About Karuna Pharma
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.50 M.
Ramesh Gupta, Vinod Gupta, and Ritesh Gupta serve as directors at the Company.
- CIN/LLPIN
U99999TG1995PTC020406
- Company No.
020406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Karuna Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Gupta  | Managing Director | 22-May-1995 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Gupta | Whole-Time Director | 20-Aug-2000 | Current |
| Ritesh Gupta | Whole-Time Director | 26-Jun-2013 | Current |
Financial Performance of Karuna Pharma.
Karuna Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.91% decrease. The company also saw a substantial fall in profitability, with a 38.7% decrease in profit. The company's net worth Soared by an impressive increase of 11.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karuna Pharma?
In 2021, Karuna Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 24 Oct 1997 | ₹2.50 M | Open |
How Many Employees Work at Karuna Pharma?
Karuna Pharma has a workforce of 31 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karuna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karuna Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
